Skip to main content
Michael Scordo, MD, Hematology, New York, NY

Michael Scordo MD

Hematologic Oncology


Assistant Attending, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center

Request Appointment
  • 530 East 74th StreetNew York, NY 10021

  • Book by Phone+1(231) 508-9619

Overview of  Dr. Scordo

I am a medical oncologist and hematologist who specializes in caring for people with hematologic malignancies who are undergoing hematopoietic cell transplantation. I have a particular interest in lymphoma and multiple myeloma.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2011
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • CT State Medical License
    CT State Medical License 2023 - 2025
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2014 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
    Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Dynamic Easix Scores Closely Predict Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation
    Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
    Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Career-Development Lunch Sessions: Adult Clinical Malignant Hematology/BMT 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: